Compounds > clopidogrel

clopidogrel and Diabetic Retinopathy

clopidogrel has been researched along with Diabetic Retinopathy in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, JS; Mahmoud, TH1
Arrebola, M; De La Cruz, P; de la Cuesta, FS; González-Correa, A; Martinez-Cerdán, E; Moreno, A1
Dagher, Z; Gerhardinger, C; Hoehn, T; Lorenzi, M; Sun, W1

Other Studies

4 other study(ies) available for clopidogrel and Diabetic Retinopathy

ArticleYear
Recommendations on the Clinical Use of Compound Danshen Dripping Pills.
    Chinese medical journal, 2017, Apr-20, Volume: 130, Issue:8

    Topics: Angina Pectoris; Aspirin; Camphanes; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Drugs, Chinese Herbal; Humans; Meta-Analysis as Topic; Panax notoginseng; Salvia miltiorrhiza; Ticlopidine

2017
Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:10

    Topics: Anticoagulants; Aspirin; Clopidogrel; Diabetic Retinopathy; Female; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Hemorrhage; Warfarin

2011
Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2003, Volume: 367, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Clopidogrel; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Male; Nitrates; Nitric Oxide; Nitrites; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Retinal Vessels; Thromboxane B2; Ticlopidine

2003
Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects.
    Diabetes, 2005, Volume: 54, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dinoprostone; Humans; Neurons; Platelet Aggregation Inhibitors; Rats; Retina; Retinal Vessels; Ticlopidine

2005